Julia Lainster

While the Cas9 protein effectively targets specific DNA sequences, its inherent biochemical flexibility allows for unintended cleavage at genomic sites that closely resemble the intended target. This fundamental challenge persists even as the medical community celebrates the clinical success of

The inclusion of telehealth follow-ups facilitates the participation of family members and caregivers who might not be available for traditional mid-day home visits. This regulatory update, which takes effect on November 1, represents a landmark shift in Australian pharmacy practice by allowing

Small-scale nanoparticles are uniquely capable of penetrating the dense architecture of biofilms to disrupt the quorum sensing communication that bacteria use to maintain their survival. This revelation comes at a time when the global medical community is facing a significant crossroads, as the

The landscape of influenza infection is characterized by extreme heterogeneity, where many cells fail to produce a complete set of viral genes due to packaging errors. This fundamental challenge means that the survival of a specific viral lineage often depends more on the logistical circumstances

Genetic blueprints have long been visualized as sleek, predictable spirals, yet the hidden reality of our DNA involves complex architectural knots that could hold the secret to dismantling the most aggressive forms of human cancer. While the Watson-Crick double helix remains the foundation of

The medical community stands at a crossroads where the convenience of AI-designed diagnostics must be balanced against the rigorous demands of patient safety and survival statistics. As of the current count in 2026, the US Food and Drug Administration has authorized exactly 1,524 AI-enabled medical

Zai Lab Limited’s early results for zocilurtatug pelitecan (zoci) offer a reason to advance a platinum-free treatment approach for extensive-stage small-cell lung cancer (ES-SCLC). The next development question is practical: can the company turn this encouraging small-study signal into reliable

A lack of standardized data elements across different tumor types makes it difficult for researchers to track patient outcomes over long periods. This fundamental challenge often forces life sciences companies to rely on fragmented information that fails to capture the true complexity of a

The security of sensitive medical records remains a paramount concern for patients and providers alike, especially as high-volume diagnostic services transition to centralized cloud architectures. Quest Diagnostics, a cornerstone of the American pathology landscape, recently disclosed a

The global biotechnology market currently stands at a transformative crossroad as the latest findings from BioNTech’s clinical pipeline indicate that the roadmap for oncology is significantly more nuanced than the rapid success of COVID-19 vaccines once suggested. This announcement, while initially